Laura serves as the Director of Billing and Biologic Operations at DMV Allergy & Florida Allergy, bringing more than two decades of experience in allergy, asthma, and immunology practice management.

Recognized nationally for her expertise in biologic therapies, medical billing, coding, and practice operations, Laura has played an instrumental role in helping allergy practices implement innovative treatments while optimizing patient access and reimbursement. She has served on multiple committees within the American College of Allergy, Asthma & Immunology (ACAAI), including the Practice Management Committee, Billing & Coding Committee, Practice Management Subcommittee, and Biologics & Pharmacology Committee, where she has contributed to advancing best practices across the specialty.

Throughout her career, Laura has collaborated with leading pharmaceutical organizations as a key opinion leader and advisory board member for the launch and implementation of numerous biologic therapies. Her experience includes national speaking engagements, participation in clinical research initiatives, and consulting on operational strategies that improve both patient outcomes and practice efficiency.

At our offices, Laura oversees billing and biologic programs, ensuring patients receive timely access to advanced therapies while supporting the organization’s commitment to exceptional clinical and operational excellence. Her passion for innovation, patient advocacy, and operational excellence continues to strengthen the care experience for patients and providers alike.